Trial intelligence / Profile preview

Surufatinib combined with chemotherapy for pancreatic cancer

ChiCTR2500095550Phase 2Not yet recruiting

Sponsor

Shandong Provincial Hospital Affiliated to Shandong First Medical University

Start

Jan 2025

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1